RNF8 and hepatocellular carcinoma: We confirmed the higher expression of RNF8 in HCC cells and tissues and further revealed that RNF8 deficiency exerted an inhibitory effect on HCC by regulating cell migration, EMT and drug sensitivity to sorafenib and lenvatinib, which holds promise for its clinical application in HCC patients.